Indxx Medical Devices ETF FT (MDEV)

West Pharmaceutical Services has trailed behind the broader market over the past year, yet analysts remain highly optimistic, standing by its potential for a strong rebound.

Mettler-Toledo International has outperformed its industry peers this year, yet Wall Street analysts maintain a cautious outlook on the stock's future potential.

West Pharmaceutical Services has underperformed other medical devices stocks over the past year, yet analysts remain bullish on the stock’s prospects.

Danaher has underperformed the Medical Devices industry, though Wall Street analysts remain strongly optimistic about its future prospects.

While Thermo Fisher Scientific has underperformed the broader medical device industry recently, analysts remain optimistic about the company's future outlook.

West Pharmaceutical Services has substantially underperformed the broader market year over the past year, yet analysts remain bullish on the stock’s prospects.

Despite Revvity’s underperformance compared to its industry peers over the past year, Wall Street analysts remain moderately optimistic about the stock’s prospects.

Despite Align Technology’s underperformance relative to the broader market over the past year, Wall Street analysts remain moderately bullish about the stock’s prospects.

West Pharmaceutical Services has underperformed the broader market over the past year, but Wall Street analysts remain optimistic about the stock’s prospects.

Thermo Fisher Scientific has underperformed relative to the broader market over the past year, yet analysts are bullish on the stock's potential.